c-MYC protein expression and c-MYC aneuploidy could predict worse survival in patients with ALCL

Osteosarcoma was the most popular primary malignant tumor in children and adolescent, and the 5-year survival of osteosarcoma patients gained no...

First-line treatment of patients with recurrent, metastatic prostate cancer involves hormone therapy with or without additional systemic therapies.

Long noncoding RNAs (lncRNAs) are emerging as crucial contributors to the development of breast cancer and are involved in the stemness regulation of...

Although a growing body of evidence supports an early-life contribution to prostate cancer development, few studies have investigated early-life diet